{"schema_version":"1","generated_at":"2026-11-12T16:23:26.429Z","data_as_of":null,"url":"https://www.findmykol.com/kol/margarita-cancio","json_url":"https://www.findmykol.com/kol/margarita-cancio/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"margarita-cancio","name":"Margarita Cancio","credential":"MD","specialty":"Infectious Disease","specialty_raw":"Infectious Disease","therapeutic_area":"Infectious Disease","therapeutic_areas":["Infectious Disease"],"city":"Tampa","state":"FL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1730162348","openalex":"A5111706699"},"summary":"Margarita Cancio is an Infectious Disease physician. OpenAlex indexes 18 publications with 374 citations (h-index 5).","overview":null,"focus":{"indications":[],"research_topics":["Infectious Disease"]},"scholarship":{"works_count":18,"cited_by_count":374,"h_index":5,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":19,"program_years":{"first":2021,"last":null},"rows_total":47,"shown":3,"withheld":44,"rows":[{"payer":"Insmed, Inc.","program_year":2025,"amount_usd":336.83,"payment_count":8,"source_url":"https://openpaymentsdata.cms.gov/search?query=1730162348"},{"payer":"Gilead Sciences, Inc.","program_year":2025,"amount_usd":210.07,"payment_count":8,"source_url":"https://openpaymentsdata.cms.gov/search?query=1730162348"},{"payer":"Astellas Pharma US Inc","program_year":2025,"amount_usd":182.06,"payment_count":6,"source_url":"https://openpaymentsdata.cms.gov/search?query=1730162348"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1730162348","source":"payments"},"prescribing":{"data_year":2024,"areas_total":8,"areas_shown":3,"areas":[{"area":"Anti-infectives","share_pct":34.3,"classes_total":12,"classes":[{"class":"Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor","setting":"prescribed","share_pct":9.9,"drugs":[{"name":"Juluca","share_pct":33.6},{"name":"Tivicay","share_pct":21.6},{"name":"Dovato","share_pct":19.2},{"name":"Isentress","share_pct":16.8},{"name":"Cabenuva","share_pct":8.8}],"max_beneficiaries":null},{"class":"Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor","setting":"prescribed","share_pct":4.3,"drugs":[{"name":"Triumeq","share_pct":61.1},{"name":"Descovy","share_pct":38.9}],"max_beneficiaries":null}]},{"area":"Cardiovascular","share_pct":26.5,"classes_total":8,"classes":[{"class":"Statin","setting":"prescribed","share_pct":10,"drugs":[{"name":"Rosuvastatin Calcium","share_pct":50},{"name":"Atorvastatin Calcium","share_pct":16.7},{"name":"Pravastatin Sodium","share_pct":15.9},{"name":"Livalo","share_pct":8.7},{"name":"Pitavastatin Calcium","share_pct":8.7}],"max_beneficiaries":null},{"class":"Angiotensin receptor blocker (ARB)","setting":"prescribed","share_pct":4.8,"drugs":[{"name":"Losartan Potassium","share_pct":100}],"max_beneficiaries":11}]},{"area":"Nervous system","share_pct":14.5,"classes_total":6,"classes":[{"class":"Benzodiazepine","setting":"prescribed","share_pct":7,"drugs":[{"name":"Clonazepam","share_pct":33},{"name":"Temazepam","share_pct":23.9},{"name":"Alprazolam","share_pct":22.7},{"name":"Lorazepam","share_pct":20.5}],"max_beneficiaries":null},{"class":"SSRI","setting":"prescribed","share_pct":3.6,"drugs":[{"name":"Sertraline Hcl","share_pct":71.1},{"name":"Escitalopram Oxalate","share_pct":28.9}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":61.2,"facility_pct":38.8},"source":"medicare"},"publications":{"total":18,"shown":5,"withheld":13,"matched_by":"OpenAlex author record","recent":[{"title":"Atypical Mycobacterium Skin Infection in a Heart Transplant Patient","year":2024,"journal":"Cureus","source_url":"https://doi.org/10.7759/cureus.72887","status":"verified"},{"title":"479. Real-world Evaluation of SARS-CoV-2 Monoclonal Antibodies in Solid Organ Transplant Recipients","year":2021,"journal":"Open Forum Infectious Diseases","source_url":"https://doi.org/10.1093/ofid/ofab466.678","status":"verified"},{"title":"Outbreak of Carbapenem-Resistant Enterobacteriaceae at a Long-Term Acute Care Hospital: Sustained Reductions in Transmission through Active Surveillance and Targeted Interventions","year":2012,"journal":"Infection Control and Hospital Epidemiology","source_url":"https://doi.org/10.1086/667738","status":"verified"},{"title":"Significant Reduction of Ventilator-Associated Pneumonia Rates Associated With the Introduction of a Prevention Protocol and Maintained for 10 Years","year":2010,"journal":"ICU Director","source_url":"https://doi.org/10.1177/1944451610370015","status":"verified"},{"title":"Prevention of Infection Caused by Gram-Positive Bacteria in the Bloodstream and Lungs","year":2010,"journal":"Infection Control and Hospital Epidemiology","source_url":"https://doi.org/10.1086/655439","status":"verified"}],"source":"works"},"contact":{"address_1":"4729 N HABANA AVE","city":"Tampa","state":"FL","zip":"336147113","phone":"813-251-8444","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1730162348","source":"identity"},"similar":[{"name":"Thomas Walsh","slug":"thomas-walsh","institution":"Cornell University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/thomas-walsh","json_url":"https://www.findmykol.com/kol/thomas-walsh/profile.json"},{"name":"Douglas Richman","slug":"douglas-richman","institution":"University of California San Diego","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/douglas-richman","json_url":"https://www.findmykol.com/kol/douglas-richman/profile.json"},{"name":"Henry Masur","slug":"henry-masur","institution":"National Institutes of Health","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/henry-masur","json_url":"https://www.findmykol.com/kol/henry-masur/profile.json"},{"name":"Vance Fowler","slug":"vance-fowler","institution":"Duke University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/vance-fowler","json_url":"https://www.findmykol.com/kol/vance-fowler/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":44,"publications":13}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-08-22","provider_certified":"2022-08-22","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}